As nirsevimab and clesrovimab are the first products of their kind, there are many things to consider when implementing in a clinical setting. Below are various resources to support implementation in both inpatient and outpatient settings.

Hospital/Inpatient Resources

General Resources

Last Updated

10/13/2025

Source

American Academy of Pediatrics